MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer
Xinxue Zhang(Southeast University), Qiang He(Capital Medical University)
Cited by 7
Related Papers
Silibinin: a potential old drug for cancer therapy
|Expert Review of Clinical Pharmacology|2016|64